Synapse - Breast Medicine Service

Results (4181)

Mechanisms of integration for androgen receptor and phosphatidylinositol 3-kinase signaling in estrogen receptor negative class A breast cancer

Meeting Abstract

Jamshidi, F.; Zhang, L. Y.; Heguy, A.; Doane, A.; Gerald, W.; Bromberg, J.; Hudis, C.
Cancer Research (2011)

Fulltext@MSK | Save

Activating MEK1(F129L) mutation as a potential mechanism of acquired resistance to MEK inhibition in human cancers carrying the B-RafV600E mutation

Meeting Abstract

Niu, H. F.; Wang, H. S.; Daouti, S.; Li, W. H.; Wen, Y.; Rizzo, C.; Higgins, B.; Packman, K.; Rosen, N.; Boylan, J. F.; more...
Cancer Research (2011)

Fulltext@MSK | Save

CH5126766 is a novel allosteric inhibitor of MEK that prevents its phosphorylation by RAF

Meeting Abstract

Ishii, N.; Harada, N.; Sakamoto, H.; Matsuda, Y.; Tomii, Y.; Tachibana-Kondo, Y.; Miura, T.; Ohara, K.; Iikura, H.; Aoki, T.; more...
Cancer Research (2011)

Fulltext@MSK | Save

Inhibition of IL-6/Jak/Stat3 signaling: A novel and potent targeting therapy for lung cancer

Meeting Abstract

Gao, S. Z. P.; Mao, N. H.; Schori, E.; Liu, S. H.; Daly, L.; Barlas, A.; Gueorguiev, V. D.; Zhao, H. Y.; Qiu, J.; Hefter, B.; more...
Cancer Research (2011)

Fulltext@MSK | Save

Inhibition of PI3K-AKT signaling causes a FOXO-dependent induction of receptor tyrosine kinase expression and phosphorylation in cancer

Meeting Abstract

Chandarlapaty, S.; Sawai, A.; Rodrik-Outmezguine, V.; Scaltriti, M.; Serra, V.; Baselga, J.; Rosen, N.
Cancer Research (2011)

Fulltext@MSK | Save

Physical and psychological sequelae of breast cancer in men

Meeting Abstract

Ruddy, K. J.; Giobbie-Hurder, A.; Giordano, S. H.; Goldfarb, S.; Kereakoglow, S.; Winer, E. P.; Partridge, A. H.
Cancer Research (2011)

Fulltext@MSK | Save

Tesetaxel, an oral taxane, as first-line therapy for women with metastatic breast cancer

Meeting Abstract

Schwartzberg, L.; Rubin, P.; Patnaik, A.; Itri, L.; Olson, A. L.; Seidman, A. D.
Cancer Research (2011)

Fulltext@MSK | Save

Randomized phase II trial of weekly vs. q 2-weekly vs. q 3-weekly nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for metastatic breast cancer

Meeting Abstract

Seidman, A. D.; Conlin, A. K.; Bach, A.; Forero-Torres, A.; Wright, G.; Hackney, M. H.; Clawson, A.; Schofield, D.; Iglesias, J.; Hudis, C. A.
Cancer Research (2011)

Fulltext@MSK | Save

Tumor entrained neutrophils inhibit seeding in the pre-metastatic lung

Meeting Abstract

Granot, Z.; Heneke, E.; Comen, E. A.; King, T. A.; Norton, L.; Benezra, R.
Cancer Research (2011)

Fulltext@MSK | Save

Beyond HER2 and hormonal agents: The heat shock protein 90 inhibitor ganetespib as a potential new breast cancer therapy

Meeting Abstract

Friedland, J. C.; Sang, J.; Modi, S.; Bradley, R.; Ei-Hariry, I.; Wada, Y.; Proia, D. A.
Cancer Research (2011)

Fulltext@MSK | Save